Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3020 (LINC03020)

Target
LINC03020
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 3020 (LINC03020) is a member of the long intergenic non-coding RNA (lincRNA) family, a subgroup of long non-coding RNAs (lncRNAs) that are longer than 200 nucleotides and do not overlap with annotated protein-coding genes[3][5]. LincRNAs are known to perform diverse regulatory functions in the cell, including chromatin remodeling, regulation of transcription, acting as molecular scaffolds, decoys, or sponges for proteins and microRNAs, and fine-tuning gene expression in a tissue-specific manner[1][5]. However, there are currently no published studies that detail the specific biological roles, disease associations, or therapeutic potential of LINC03020 itself. LINC03020 has gene entries in major databases, such as NCBI Gene (101926892) and Ensembl (ENSG00000253967), confirming its annotation as a non-protein-coding transcript[3]. It is not recognized as a therapeutic target or a known biomarker, and no drugs or safety concerns are associated with it.

Other names
LINC03020
02

Biological functions

Regulation of gene expressionChromatin modificationRNA scaffold or decoyPossible involvement in cell proliferation and apoptosis (general lincRNA functions)Other
03

Disease associations

Other (general lincRNAs can be implicated in cancer and other diseases, but there is no specific disease association for LINC03020 in available sources)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3020 (LINC03020).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3020 (LINC03020).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call